Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-29T01:56:07.290Z Has data issue: false hasContentIssue false

„Sms-the subjective mania scale“

Published online by Cambridge University Press:  16 April 2020

M. Freidl
Affiliation:
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
F. Friedrich
Affiliation:
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
G. Kaiser
Affiliation:
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
J. Wancata
Affiliation:
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Non-adherence of medication still is a major problem among patients suffering from bipolar disorders.

Objectives

Previous studies focused mainly on possible side-effects, attitudes and subjective well-being. Most scales concerning this issue have been developed by psychiatric experts and based on their knowledge not on the patients points of view.

Aims

The purpose of this study was to find out what kind of drug effects the patients themselves want.

Methods

2 focus-groups with 13 patients and In-depth interviews with 15 mania patients were conducted to collect information about subjective burden and symptoms of the illness. Content analyses of the transcriptions were performed and the results were used to develop a first draft of the questionnaire.

Results

The final German test version consists of 32 items and is called “The Subjective Mania Scale”. The study of content-validity showed that all SMS items were considered to be important by more than 50% of the sample. Test-retest reliability and sensitivity to change were evaluated. All SMS-items showed a significant change between time-point 1 and 3.

Conclusion

The SMS-rating scale is a feasible, reliable and valid instrument for clinical trials among mania patients.

Type
P01-207
Copyright
Copyright © European Psychiatric Association 2011
Submit a response

Comments

No Comments have been published for this article.